Clinical Trial Update: Bioinformation Therapy for Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

An update on a Phase 2/Phase 3 trial of a bioinformation therapy for small-cell lung cancer, with the study status listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Bioinformation Therapy

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Small-cell Lung Cancer | Phase 2, Phase 3 | Status: COMPLETED